From Research to Real-World Screening: DiCE at the European Cancer Policy Summit
DiCE joined the European Cancer Screening and Early Detection Policy Summit in Brussels, contributing TOGAS insights on implementation, citizen per...
A Promising Step Forward in Pancreatic Cancer Research
New preclinical research explores a three-drug strategy targeting KRAS, EGFR/HER2 and STAT3 pathways in pancreatic ductal adenocarcinoma. In labora...
New Population-based Helicobacter pylori Screen-and-Treat Strategies for Gastric Cancer Prevention: Guidance on Implementation Report
DiCE’s latest study, now published in BMC Gastroenterology, captures the experiences of 47 people under 50 diagnosed with colorectal cancer. Fin...
DiCE Advocates for Patient-Centred Innovation at CDDF Workshop
DiCE joined experts at the CDDF Workshop to explore breakthroughs in oncology, including targeted therapies and personalised vaccines. We emphasise...
DiCE at the AIDA General Assembly 2025
The AIDA General Assembly 2025 occurred from March 24 to 25 at Imperial College London. It brought together experts, researchers, and consortium me...
PERT Shortages and the Impact on Pancreatic Cancer Patients
For many patients with pancreatic cancer, as well as those who have undergone a pancreatectomy, or live with chronic pancreatitis or cystic fibrosi...
DiCE Advocates for Awareness at PANCAID Stakeholder Event
On 15 January 2025, DiCE actively participated in the PANCAID Stakeholder Event at the European Parliament in Brussels, organised by Pancreatic Can...
IMPROVE-2 Trial: A New Treatment Approach for mCRC
The IMPROVE-2 trial is exploring a new way to treat metastatic colorectal cancer (mCRC) by comparing intermittent versus continuous use of Panitumu...
Educational Programme on Metastatic Pancreatic Cancer Now Available
Metastatic pancreatic ductal adenocarcinoma (mPDAC) is an aggressive and often late-diagnosed cancer with poor prognoses. Early detection remains c...
Advancing Rare Cancer Care: DiCE at the EURACAN Board Meeting
On the 7th and the 8th of November, Laura Urena from Digestive Cancers Europe (DiCE) and a member of EURACAN Patient Advocacy Group (EPAG), partici...